These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4633084)

  • 41. [Research on the in vitro antibacterial activity of gentamicin].
    Petrini M; Cava L; Grassi L
    Minerva Med; 1967 Nov; 58(95 Suppl):4196-4207. PubMed ID: 4966209
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro comparison of gentamicin and netilmicin including a regression line for netilmicin.
    Bang J; Mortensen I; Bentzon MW
    Scand J Infect Dis Suppl; 1980; Suppl 23():34-8. PubMed ID: 6782656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gentamicin-resistant Pseudomonas aeruginosa corneal ulcers.
    Gelender H; Rettich C
    Cornea; 1984; 3(1):21-6. PubMed ID: 6443074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Extra-chromosomal resistance in Enterobacteriaceae and Staphylococcus].
    Chabbert YA; Baudens JG; Bouanchaud D
    Pathol Biol; 1967 Dec; 15(23):1173-8. PubMed ID: 4867324
    [No Abstract]   [Full Text] [Related]  

  • 45. Letter: Gentamicin-resistant Pseudomonas aeruginosa.
    Meyer RD
    Lancet; 1976 May; 1(7969):1136-7. PubMed ID: 57554
    [No Abstract]   [Full Text] [Related]  

  • 46. R factors in gentamicin-resistant organisms causing hospital infection.
    Richmond AS; Simberkoff MS; Rahal JJ; Schaefler S
    Lancet; 1975 Dec; 2(7946):1176-8. PubMed ID: 53660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ["In vitro" activity of gentamicin. Research of bacterial strains isolated from various forms of morbidity].
    Panero C; Pieri J
    G Ital Chemioter; 1969; 16(1):60-3. PubMed ID: 4998311
    [No Abstract]   [Full Text] [Related]  

  • 48. [Transferable resistance to gentamicin. I. Expression of the resistance character].
    Witchitz JL; Chabbert YA
    Ann Inst Pasteur (Paris); 1971 Dec; 121(6):733-42. PubMed ID: 4948138
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of combined gentamicin-corticosteroid treatment on gentamicin-resistant Pseudomonas keratitis.
    Stern GA; Okumoto M; Friedlaender M; Smolin G
    Ann Ophthalmol; 1980 Sep; 12(9):1011-4. PubMed ID: 6821445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Letter: Temperature-sensitivity and gentamicin-resistance in Pseudomonas aeruginosa.
    Seal DV; Strangeways JE
    Lancet; 1975 Sep; 2(7933):500-1. PubMed ID: 51309
    [No Abstract]   [Full Text] [Related]  

  • 51. Resistance of gram-negative bacilli to gentamicin.
    Snelling CF; Ronald AR; Cates CY; Forsythe WC
    J Infect Dis; 1971 Dec; 124 Suppl():S264-70. PubMed ID: 5001625
    [No Abstract]   [Full Text] [Related]  

  • 52. Pseudomonas aeruginosa with exceptionally high resistance to gentamicin in hospital wards. Susceptibility and phage typing.
    Yourassowsky E; Schoutens E; Beumer J
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):927-9. PubMed ID: 5003572
    [No Abstract]   [Full Text] [Related]  

  • 53. Gentamicin, theoretical and applied microbiology.
    Modde HK
    G Ital Chemioter; 1969; 16(1):7-10. PubMed ID: 4998313
    [No Abstract]   [Full Text] [Related]  

  • 54. Transferable resistance to gentamicin and other antibiotics in Enterobacteriaceae isolates from municipal wastewater.
    Králiková K; Krcméry V; Krcméry V
    J Hyg Epidemiol Microbiol Immunol; 1984; 28(2):161-6. PubMed ID: 6470479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of assay for gentamicin.
    Phillips PE; Smith DH; Smith AL
    N Engl J Med; 1972 Jun; 286(23):1266-7. PubMed ID: 4553971
    [No Abstract]   [Full Text] [Related]  

  • 57. [Genetic determinants of resistance to streptomycin and sulfanilamides in Pseudomonas aeruginosa and enterobacteria].
    Anisimova LA; Erova TE; Viatkina GG; Boronin AM
    Mol Gen Mikrobiol Virusol; 1986 Sep; (9):3-8. PubMed ID: 3097529
    [No Abstract]   [Full Text] [Related]  

  • 58. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
    Mutnick AH; Rhomberg PR; Sader HS; Jones RN
    J Antimicrob Chemother; 2004 Feb; 53(2):290-6. PubMed ID: 14711839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Resistance to gentamycin in Slovakia studied by computer. Dynamics during the 1972 to 1982 period].
    Krcméry V; Calpas S; Janousková J; Menkyna R
    Cas Lek Cesk; 1984 May; 123(19):566-9. PubMed ID: 6744373
    [No Abstract]   [Full Text] [Related]  

  • 60. [In vitro activity of cefotaxime (HR 756) compared with cephalexin, gentamycin and amikacin against Gram-negative bacteria and urinary infections].
    Silva J; Herrera N; Urdanivia R; Becerra S; Godoy J; Anderson H; Jofre M
    Rev Med Chil; 1983 Jul; 111(7):699-703. PubMed ID: 6096950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.